Enhanced expression of decay-accelerating factor and CD59/homologous restriction factor 20 in intestinal metaplasia, gastric adenomas and intestinal-type gastric carcinomas but not in diffuse-type carcinomas

Histopathology

Volumn 40, Issue 4, 2002, Pages 339-347

  Kiso, T ^a   Mizuno, M ^a   Nasu, J ^a   Shimo, K ^a   Uesu, T ^a   Yamamoto, K ^a   Okada, H ^a   Fujita, T ^b   Tsuji, T ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD59; Complement; Decay accelerating factor; Gastric carcinoma; Membrane cofactor protein

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY;

ADENOMA; ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL SURFACE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GASTRECTOMY; GASTROSCOPY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; STOMACH; STOMACH ADENOMA; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR CELL;

ADENOMA; ANTIGENS, CD55; ANTIGENS, CD59; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0036275179     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01350.x     Document Type: Article

References (36)

1. Quantitative analysis of MCP on human leukemia cell lines, which is down-regulated during cell differentiation
2. Persistent complement activation on tumor cells in breast cancer
3. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma
4. Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation
5. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46)
6. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and body fluids
7. Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells
8. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo
9. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer
10. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis
11. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system
12. The mechanism of action of decay-accelerating factor (DAF); DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb
13. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels
14. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
15. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b
16. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas
17. Expression of CD59, a complement regulatory protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium
18. CD55 is over-expressed in the tumour environment
19. The histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinomaa
20. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
21. Periodate-lysine-paraformaldehyde fixative: A new fixative for immunoelectron microscopy
22. Antibody-induced antigenic modulation is antigen dependent: Characterization of 22 proteins on a malignant human B cell line
23. Peroxidase-labeled antibody: A new method of conjugation
24. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells
25. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC)
26. Decay-acclerating factor of complement is anchored to cells by a C-terminal glycolipid
27. Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearances
28. Molecular mechanism of stomach carcinogenesis
29. Infrequent point mutations of ras oncogenes in gastric cancers
30. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers
31. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia
32. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies
33. Signal transduction through MAP kinase cascades
34. Epidermal growth factor induces expression of decay-accelerating factor in human colonic cancer cells via the mitogen-activated protein kinase pathway
35. Altered expression of membrane inhibitors of complement in human gastric epithelium during Helicobacter-associated gastritis
36. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer